Steven P Balk

发表

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

Tao Liu, Housheng Hansen He, X Shirley Liu, 2013, Epigenetics & Chromatin.

SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.

Hongyun Wang, Michael Wegner, I. Leav, 2008, Cancer research.

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.

Kenneth N Ross, K. Ross, S. Balk, 2006, Cancer research.

PTEN-deficient tumors depend on AKT2 for maintenance and survival.

A. Toker, Y. R. Chin, S. Balk, 2014, Cancer discovery.

AR and ER interaction with a p21-activated kinase (PAK6).

S. Balk, K. Swanson, Michael L Lu, 2002, Molecular endocrinology.

Whole Transcriptome Sequencing Reveals Extensive Unspliced mRNA in Metastatic Castration-Resistant Prostate Cancer

Wei Li, Hao Zhao, Zheng Xia, 2014, Molecular Cancer Research.

Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor*

G. Bubley, S. Balk, Michael L Lu, 2002, The Journal of Biological Chemistry.

Development of androgen receptor antagonists with promising activity in castration-resistant prostate cancer.

Howard C. Shen, S. Balk, Steven P Balk, 2009, Cancer cell.

Androgen receptor as a target in androgen-independent prostate cancer.

S. Balk, Steven P Balk, 2002, Urology.

ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.

Hongyun Wang, Housheng Hansen He, X Shirley Liu, 2013, The Journal of clinical investigation.